Thursday, December 5, 2013

IMPORTANT TO WATCH and NOTE OF IMPORTANCE: To monitor how the FDA and State Boards of Pharmacy Are regulating compounding pharmacies, Congress commissioned a Government Accountability Office study to be submitted to Congress within three years of the DQSA enactment that includes a review of pharmacy compounding by state and an evaluation of the effectiveness of the communication between the FDA and state pharmacy boards.


No comments: